A Study of Ixazomib Plus Lenalidomide and Dexamethasone in Adult Japanese Participants With Relapsed and/or Refractory Multiple Myeloma

NCT02917941 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed and/or Refractory Multiple Myeloma

Interventions

DRUG: Ixazomib
DRUG: Lenalidomide
DRUG: Dexamethasone

Sponsor

Takeda